Management of Blisters After Doxycycline Use

Introduction to Doxycycline-Induced Reactions

• The American Academy of Dermatology recommends stopping doxycycline immediately and seeking urgent medical evaluation if blisters occur, as they may represent a serious photosensitivity reaction or a severe hypersensitivity syndrome 1

Clinical Assessment and Treatment Approach

• The American Academy of Dermatology suggests that mucosal involvement, such as oral, ocular, or genital mucosa involvement, indicates a potential severe cutaneous adverse reaction requiring immediate hospitalization 1
• The American Academy of Dermatology recommends topical corticosteroids for phototoxic reactions with blistering, as well as strict photoprotection during healing 1
• The Centers for Disease Control and Prevention recommends immediate hospitalization for suspected severe hypersensitivity reactions, along with systemic corticosteroids and supportive care and monitoring 2, 3

Alternative Treatment Options

• The American Academy of Dermatology suggests considering alternative tetracyclines, such as minocycline, which has a lower photosensitivity risk, for acne treatment 1
• The Centers for Disease Control and Prevention recommends discussing alternative regimens with a provider for STI treatment or prevention, as doxycycline is preferred for certain indications but alternatives exist 2, 3

Management of Cutaneous Adverse Reactions

Supportive Care Measures

• The American Society of Clinical Oncology recommends applying emollients and moisturizers to prevent skin dehydration and support healing in patients with cutaneous adverse reactions 4
• The American Society of Clinical Oncology suggests avoiding hot showers, excessive soap use, and any irritating topical products to reduce skin irritation in patients with cutaneous adverse reactions 4
• The American Society of Clinical Oncology advises against manipulating or picking at blistered areas to reduce infection risk in patients with cutaneous adverse reactions 4
• The American Society of Clinical Oncology recommends avoiding topical steroids without proper supervision in some contexts, as they may cause perioral dermatitis and skin atrophy if used inadequately 4